BostonGene-Integrated Genomic Registry (BIGR)
ConditionMalignancy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorBostonGene
About this trial
The purpose of this project is to develop a comprehensive database of genomic, transcriptomic, molecular, and clinical characteristics of oncology patients to discover, define, and develop genomic and transcriptomic markers to improve future clinical outcomes across cancer types
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Suspected or confirmed malignancy
Planned comprehensive genomic (> 100 genes) and/or molecular analysis; or genomic and/or molecular data available from prior sequencing
Baseline demographics and treatment information available
Willingness for future contact by BIRG study personnel to provide information regarding associated cancer outcomes and treatment.
Disqualifiers
None
Trial population
Subjects will be identified for the BIGR study from a larger group of patients undergoing BostonGene clinical testing (e.g., BostonGene Tumor Portrait TestTM).
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
association between major finding and outcome, Descriptive
associations between genomic findings and outcomes of cancer patients who have undergone comprehensive sequencing.
Time frame
5 yearsSecondary outcomes
1
Predictive probability
identify molecular findings associated with therapy.
Time frame
5 years2
Clinical trials matching
identify and link registry subjects to future molecular-based clinical research
Time frame
5 years Source ClinicalTrials.gov